Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Net Margin (2019 - 2023)

Historic Net Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 0.33%.

  • ADC Therapeutics' Net Margin fell 666400.0% to 0.33% in Q3 2023 from the same period last year, while for Dec 2023 it was 0.29%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 74.22% for FY2022, which is 6584600.0% up from last year.
  • As of Q3 2023, ADC Therapeutics' Net Margin stood at 0.33%, which was down 666400.0% from 0.24% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Net Margin registered a high of 14019310.34% during Q3 2020, and its lowest value of 15894.14% during Q4 2019.
  • In the last 5 years, ADC Therapeutics' Net Margin had a median value of 17.92% in 2022 and averaged 1002311.61%.
  • In the last 5 years, ADC Therapeutics' Net Margin soared by 2000000000bps in 2020 and then plummeted by 2000000000bps in 2021.
  • ADC Therapeutics' Net Margin (Quarter) stood at 15894.14% in 2019, then soared by 88304bps to 14019310.34% in 2020, then crashed by -100bps to 544.22% in 2021, then crashed by -100bps to 0.0% in 2022, then plummeted by -952988bps to 0.33% in 2023.
  • Its Net Margin was 0.33% in Q3 2023, compared to 0.24% in Q2 2023 and 0.31% in Q1 2023.